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Abstract/Summary 
Background: Recently under the Connected Health initiative, researchers and small-medium 
engineering companies have developed Electrocardiogram (ECG) monitoring devices that 
incorporate non-standard limb electrode positions, which we have named the Central 
Einthoven (CE) configuration. Objectives: The main objective of this study is to compare 
ECG signals recorded from the CE configuration with those recorded from the recommended 
Mason-Likar (ML) configuration. Methods: This study involved extracting two different sets 
of ECG limb leads from each patient to compare the difference in the signals. This was done 
using computer simulation that is driven by body surface potential maps. This simulator was 
developed to facilitate this experiment but it can also be used to test similar hypotheses. This 
study included, (a) 176 ECGs derived using the ML electrode positions and (b) the 176 
corresponding ECGs derived using the CE electrode positions. The signals from these ECGs 
were compared using root mean square error (RMSE), Pearson product-moment correlation 
coefficient (r) and similarity coefficient (SC). We also investigated whether the CE 
configuration influences the calculated mean cardiac axis. The top 10 cases where the ECGs 
were significantly different between the two configurations were visually compared by an 
ECG interpreter. Results: We found that the leads aVL, III and aVF are most affected when 
using the CE configuration. The absolute mean difference between the QRS axes from both 
configurations was 28° (SD = 37°). In addition, we found that in 82% of the QRS axes 
calculated from the CE configuration was more rightward in comparison to the QRS axes 
derived from the ML configuration. Also, we found that there is an 18% chance that a 
misleading axis will be located in the inferior right quadrant when using the CE approach. 
Thus, the CE configuration can emulate right axis deviation. The clinician visually identified 
6 out of 10 cases where the CE based ECG yielded clinical differences that could result in 
false positives. Conclusions: The CE configuration will not yield the same diagnostic 
accuracy for diagnosing pathologies that rely on current amplitude criteria. Conversely, 
rhythm lead II was not significantly affected, which supports the use of the CE approach for 
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assessing cardiac rhythm only. Any computerised analysis of the CE based ECG will need to 
take these findings into consideration. 
 
Introduction 
The number of persons aged over 60 is said to more than double by the year 2050 [1]. Hence, 
there will be a significant burden on healthcare services to treat the large number of elderly 
patients who have chronic diseases. Unless a new model for healthcare delivery is conceived, 
the cost for healthcare will become unprecedented. For example, the National Health Service 
(NHS) in the UK maybe forced into privatisation [2]. To help alleviate these risks, Connected 
Health (CH) has been portrayed as a potential solution [3]. CH is a form of preventative 
medicine that empowers patients to be more proactive about their health. An important part in 
this model is the use of technologies to monitor the patient’s vital signs. A number of vital 
signs including body temperature, blood pressure, respiratory rate and heart rhythm can 
already be monitored using these devices [4, 5]. Nevertheless, accurate non-invasive real-time 
monitoring of cardiac activity outside the hospital is one of the most challenging 
implementations due to its complexity and intrusiveness [6]. The Electrocardiogram (ECG) is 
frequently used in the hospital for assessing the cardiac activity of a patient [7]. An ECG 
represents the electrical activity of the heart and has been used in clinical practice for over a 
hundred years [8]. It is the gold standard for diagnosing cardiac arrhythmias [8] and is the 
first tool used to assess patients with a suspected acute myocardial infarction [8]. Given its 
diagnostic utility and the fact that an ECG can be recorded at a low cost, it was one of the first 
tools considered for 24-hour ambulatory monitoring outside the hospital [9]. Ambulatory 
ECG monitoring devices often use four electrodes to record three to six limb leads [8]. As 
recommended by the American Heart Association (AHA), these four electrodes are normally 
anatomically positioned using the Mason-Likar (ML) configuration [10]. From the four 
electrodes used, three electrodes make up Einthoven’s triangle whilst the remainder electrode 
acts as the ground. Although the ML configuration is traditionally used for ECG monitoring, 
researchers and small-medium enterprises have developed a number of teleheath devices that 
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position these electrodes at more proximal landmarks. An example product has been 
illustrated in Figure 1. It shows the extreme proximal electrode positions, which we have 
named the Central Einthoven (CE) configuration. The figure also illustrates how these 
devices can be used to stream real-time ECG data via Bluetooth and Wi-Fi to the ‘Cloud’ for 
display on a physician’s portal [11]. There are a number of reasons why these devices adopt 
the CE configuration. For example, the CE configuration is less obtrusive and improves 
patient comfort (given the electrodes are further from the limbs). Whilst the current model of 
healthcare is to monitor the ill, CH is an emerging model that encourages even healthy 
citizens to record vital signs in the home, which is often referred to as disease prevention (i.e. 
monitoring the healthy and not just the ill). Engineering companies have seen this as an 
opportunity to develop a mass of inexpensive ECG monitoring devices for home-based 
telehealth. Thus, there could be a larger movement towards citizens adopting these devices 
and this study shows how the CE configuration changes the morphology of the signals and 
the cardiac axis when compared to the recommended ML configuration.  
 
 
This study sets out to compare signals recorded using the ML configuration with signals 
recorded using the CE configuration. Others have referred to the CE configuration as the 3-
electrode system [12]. Both configurations have been illustrated in Figure 2.   
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Figure 1. (A) A wireless ECG system (Shimmer device [13]) that employs the CE 
configuration, and (B) shows how the wireless ECG recorder can use Bluetooth and Wi-
Fi to stream data to the Cloud for display on a GP’s portal. 
 
 
 
Figure 2. (A) ML configuration [14] and (B) the CE (or ‘Central Einthoven’) 
configuration where the electrodes are placed around the centre of the precordium. The 
figure also illustrates Einthoven’s triangle where the Right Arm (RA), Left Arm (LA) 
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and Left Leg (LL) electrodes make up the recording of three Einthoven limb leads (I, II, 
II) and the three augmented lead (aVR, aVL, and aVF).  
 
Methods 
This is a retrospective study that involves data from 176 Body Surface Potential Maps 
(BSPMs) that were recorded from healthy subjects who had no ECG abnormalities. It is 
imperative to analyse the effects of the CE configuration on healthy subjects for a number of 
reasons, (a) CH devices will be used by a healthy population for the purposes of the early 
detection of disease (also known as disease prevention) and (b) to determine the potential of 
false positives.   
 
The BSPMs (each having 192 leads) were collected by the cardiology faculty of the Nora 
Eccles Harrison Cardiovascular Research and Training Institute at the University of Utah. 
Subjects and patients were consented using University of Utah procedures that were approved 
by the Institutional Review Board (IRB). This approval was granted and in place at the time 
of the recordings.  
 
A BSPM is a specialised ECG recording that uses a large number of electrodes positioned 
around the entire torso [15]. Each BSPM used in this study was recorded using 192 electrodes 
[16]). Given a BSPM contains almost all of the electrocardiographic information that is 
available on the body surface, we extracted two different ECG subsets from each BSPM. This 
included subset (a) a 6-lead ECG derived from the ML configuration (Figure 2a), and subset 
(b) a 6-lead ECG derived using the CE configuration (Figure 2b). In total, we extracted 352 
ECGs from the entire dataset (176 ML 6-lead ECGs and 176 CE 6-lead ECGs). The actual 
extraction process was carried out using our Electrode Misplacement Simulator (EMS) which 
was developed at the University of Ulster [17]. Using BSPM datasets is an optimal scientific 
approach for comparing different ECG subsets for a number of reasons. The primary reason is 
that a BSPM is comprised of hundreds of ECG leads that are recorded from all parts of the 
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torso and importantly, these leads are recorded at the same ‘time period’. As such we opted to 
utilize BSPMs for our comparative study given BSPM data facilitates ‘like-for-like’ 
comparisons due to the fact that the ECG signals are recorded simultaneously. Thus, using 
BSPM data for these type of studies has become a standard approach in the research 
community [18, 19].  
 
As described in the following section, linear interpolation was performed to extract some of 
the ECG leads from the BSPM. Any interpolated leads were calculated from BSPM leads that 
were in close proximity (3cm apart), thus derivations are very accurate and likely to have an 
insignificant error. Also, this approach of near field linear interpolation amongst BSPM leads 
has previously been shown to be accurate. According to Schijvenaars et al. [20] inter-
electrode interpolations based on BSPMs yield extremely small errors that are no greater than 
signal noise often found in chest electrodes.  
 
 
Electrode misplacement simulator or EMS 
The EMS was developed by the authors and has been described elsewhere [17, 21, 22]. For 
this study, the authors enhanced the EMS software to allow the user to alter limb electrode 
locations and extract the relevant leads. This new version of the EMS is available on the 
Internet [23]. The EMS uses an algorithm to extract any limb lead variant from a BSPM. 
When the user interactively moves a limb electrode, the algorithm detects the nearest four 
BSPM leads using Euclidean distance and the signals are derived using linear interpolation as 
defined in Equation 1.    
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Equation 1.     
𝑑𝑒𝑟𝑖𝑣𝑒𝑑𝑃𝑜𝑡𝑒𝑛𝑡𝑖𝑎𝑙𝑠(!) = 𝑛𝑒𝑖𝑔ℎ𝑏𝑜𝑢𝑟𝐿𝑒𝑎𝑑 !,! ∙ 𝑟𝑎𝑡𝑖𝑜(!)!!!!  
 
where n is the number of neighbour leads (n=4). Each potential at time t is calculated by a 
summation of each of the neighbour leads multiplied by a weighted ratio. The ratio is 
weighted for each individual neighbour lead relative to its distance from the user-defined 
electrode.  More details can be found in previous papers [17, 21, 22]. 
 
Metrics for signal analysis  
Three metrics were used in this study to quantify the similarity/difference between leads 
derived from the ML and CE configurations. This comparison was performed over three 
different intervals in the ECG, i.e. the PQRST, QRS and STT intervals. Similarity metrics 
include the root mean square error (RMSE), Pearson product moment correlation coefficient 
(r) and the similarity coefficient (SC). Mean ± SD of the metrics were calculated using all of 
the data including any outliers, however outliers were removed from the boxplots to improve 
their readability and scale.  SC is described in Equation 2. 
 
Equation 2.  
   
𝑆𝐶 = 1 −    (!!!!!)!!!!! !!!!!!!!!  
 
where the denominator is the RMSE and the divisor is the Root Mean Square (RMS) of a ML 
lead. Within the divisor, xi represents a sample value from a ML lead. 
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Mean frontal QRS electrical axis 
We also compared the difference in the QRS axes as calculated from the ML and CE 
configurations. The QRS axis is not normally used in remote monitoring cases but it can be 
used to indicate structural and conduction abnormalities of the heart and other researchers 
have considered the QRS axis to be somewhat important within ECG monitoring [24, 25]. For 
each of the ML and CE configurations, the QRS axis was calculated using the orthogonal 
leads I and aVF [26] (known as the quadrant method). The calculation of the QRS axis does 
consider time as it is calculated using the R peak and S nadir of two leads (and since the R 
peak and S nadir can occur at slightly different times in different leads). This method of 
calculating the QRS axis has been defined in Equation 3.  
 
Equation 3.  
 
𝑞𝑟𝑠𝐴𝑥𝑖𝑠 = arcTan   𝑎𝑣𝑓𝑅𝑃𝑒𝑎𝑘 −   𝑎𝑣𝑓𝑆𝑁𝑎𝑑𝑖𝑟     𝑖𝑅𝑃𝑒𝑎𝑘 −   𝑖𝑆𝑁𝑎𝑑𝑖𝑟        
 
Where the numerator is calculated by subtracting the R peak (avfRPeak) in lead aVF from the 
magnitude of the S nadir (avfSNadir) also in lead aVF. Similarly, the denominator is 
calculated by subtracting the R peak (iRPeak) from the magnitude of the S nadir (|iSNadir|) in 
lead I. After calculating the QRS axis for each of the ECGs, we compared the difference in 
QRS axis angles between the two configurations. This was done by calculating the mean 
absolute axis difference as defined in Equation 4 
 
Equation 4. 
𝑚𝑒𝑎𝑛𝐴𝑏𝑠𝐴𝑥𝑖𝑠𝐷𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒 =   1𝑛    ∙ 𝑓!!!! 𝑥! , 𝑦!                        
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where  𝑚𝑒𝑎𝑛𝐴𝑏𝑠𝐴𝑥𝑖𝑠𝐷𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒 is the absolute mean average of the values returned by the 
function 𝑓(𝑥! , 𝑦!). n is the number of corresponding ECGs (n=176). 𝑥!  is the QRS axis 
calculated from a ML based ECG and 𝑦! is the corresponding QRS Axis calculated from the 
CE based ECG. The function is defined in Equation 5. 
 
Equation 5. 
 
𝑓 𝑥, 𝑦 = 360° − (|𝑥 − 𝑦|), |𝑥 − 𝑦| > 180°|𝑥 − 𝑦|, |𝑥 − 𝑦| ≤ 180°                               
 
where 𝑓 𝑥, 𝑦  returns the absolute difference between two QRS axes when the difference is 
less than or equal to 180 degrees. Otherwise the function returns the result of 360 degrees 
subtracted by the absolute difference. This ensures that the difference between two QRS axes 
is within a 0-180 degrees interval (irrespective of clockwise). We then categorised each of the 
QRS axis using the function defined in Equation 6.  
 
 
Equation 6.  
  𝑓 𝑥 = ′𝑁𝑜𝑟𝑚𝑎𝑙′, 𝑥 ≥ −30° ∧ 𝑥 ≤ 90°  ′𝐼𝑛𝑓𝑒𝑟𝑖𝑜𝑟  𝑅𝑖𝑔ℎ𝑡′, 𝑥 > 90° ∧ 𝑥 ≤ 180°'Superior Right', 𝑥 > −180° ∧ 𝑥 < −90°
'Superior Left', 𝑥 ≥ −90° ∧ 𝑥 < −30°      
 
where x is a QRS axis angle which is used by the function to determine the quadrant. For 
example, if the angle lies within -30° and 90°, the axis is determined ‘Normal’ [8]. This 
function was used in this study to investigate whether the CE configuration affects the 
quadrant classification, which is used as criteria in clinical practice. 
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Clinical observation 
An expert in ECG interpretation (senior clinical physiologist) was recruited to serially 
compare 20 ECGs (10 ECGs derived using the ML configuration against the 10 
corresponding ECGs derived using the CE configuration). These 10 cases were analysed 
because they were most affected by the CE configuration. These cases were identified using 
Equation 7, which calculates a standard composite score for each set of ECGs being 
compared. Serial comparison also removes the effect of intra-observer variability. 
 
Equation 7. 
𝒄𝒐𝒎𝒑𝒐𝒔𝒊𝒕𝒆𝑺𝒄𝒐𝒓𝒆 =   1𝑛    ∙ 𝑥! − 𝑦!𝑧!!!!! + 𝑎! − 𝑏!𝑐! ∙ −1 
Where n is the number of leads (n = 6), xi corresponds to the RMSE between the ML and the 
corresponding CL lead i (as calculated over the PQRST), yi is the mean RMSE of lead i as 
calculated over all subjects in the study population and zi is the standard deviation of the 
RMSE values associated with lead i as calculated over all subjects in the study population. 
This part of the equation calculates a standard z-value, which is used to standardise a number 
so that it becomes ‘metric agnostic’ (i.e. z-values then can be summed with z-values derived 
from other metrics). In this study, z-values derived from the RMSE values were summed with 
z-values derived from the r metric. Therefore, a represents r of a particular lead, b is the mean 
r of this lead (over all cases) and c is the standard deviation of r in this lead (over all cases). 
This particular z-value is inverted (as its multiplied by -1). The reason being is that high r 
values signify that the lead is more correlated in both the ML and CE configurations (whereas 
high RMSE values [or their associated z-values] signify that the leads are more different). 
Nevertheless, these two z-values are summed to create a composite score. This is then 
calculated for all leads, which are averaged to create a mean composite score for each case. 
These scores are then used to rank each case in descending order. Hence, the top ten scoring 
cases were used to identify which ECGs (according to signal difference) are most affected by 
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the CE configuration. These 20 ECGs were serially compared by an ECG human interpreter 
(who was blinded to which ECGs were ML or CE based to avoid bias). The ECG observer 
was requested to consider, a) whether the differences between the two contrasting ECGs are 
of clinical significance/relevance, and b) rate out of 10 the similarity between the two 
contrasting ECGs (where 1=very different and 10=very similar). 
 
Results  
Figure 3 depicts box plots of the RMSE calculated over the PQRST, QRS and STT intervals 
respectively. Each box plot excludes outliers that exceeded a threshold (outliers >= IQR*1.5). 
Figure 3a shows the RMSE values calculated over the PQRST between the six ECG leads of 
the ML and the CE configurations. Leads III (median RMSE = 132uV), aVF (median RMSE 
= 118uV) and II (median RMSE = 112uV) are the most disparate leads when comparing the 
ML and CE configurations. For reference and to aid the interpretation of these results, the 
normal amplitude values and limits for the intervals in an ECG complex are as follows: P 
amplitude=150uV±50, QRS height=1500uV±500, ST=0uV±100 and T height=300uV±200 
[27]. 
 
Figure 3b shows that the RMSE of the QRS is the highest in leads III (median RMSE = 
289uV), aVF (median RMSE = 249uV) and II (median RMSE = 230uV).  Figure 3c shows 
that the RMSE of the STT interval is again the highest in leads III (median RMSE = 82uV) 
aVF (median RMSE = 70uV) and II (median RMSE = 70uV).  
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Figure 3. (A) RMSE of the PQRST across six ECG leads. (# of upper outliers: I=13, 
II=5, III=4, aVR=5, aVL =4 and aVF=5.). (B) RMSE of the QRS complex across six ECG 
leads. (# of upper outliers: I=10, II=9, III=7, aVR=10, aVL =2 and aVF=8.). (C) RMSE 
of the STT interval across six ECG leads. (# of upper outliers: I=8, II=11, III=15, 
aVR=7, aVL =2 and aVF=21.) 
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Figures 3 indicates that lead III is the most contrasting lead. However when analysing the 
Pearson product moment correlation coefficient, lead aVL is found to correlate the least. This 
can be seen in Figure 4 in which the mean similarity metrics (i.e. RMSE, r and SC) are 
reported for the PQRST, QRS and STT intervals. According to r of the PQRST, leads aVL, 
III and I are the least correlated leads. In addition, according to the mean SC of the PQRST, 
leads aVL, III and aVF are the least similar. However, when considering all three metrics 
(Figure 4) it is leads aVL, III and aVF that are the most contrasting leads when comparing the 
two configurations.    
 
 
Figure 4. Summary of the results used to compare six leads recorded from two different 
configurations (ML and CE). The figure has three sections to show the differences in 
three signal intervals (PQRST, QRS and STT). Each section shows the results according 
to three different metrics (RMSE, r and SC). Each row is sequentially ordered to show 
the most affected lead on the right to the least affected lead on the left. The most affected 
lead is the lead that is the most ‘different’ when comparing this lead recorded from each 
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configuration. To improve its readability, each of the six ECG leads has been colour 
coded. This allows the reader to see the pattern of which intervals and leads contrast the 
least and the most. 
 
As seen in Figure 5, we found a large difference in the QRS axes that were derived using the 
two different configurations. The CE configuration was found on average to affect the 
calculated QRS axis by 28° (SD = 37°). We also found that in 82% (144/176) of the QRS 
axes calculated from the CE configuration was more rightward. In addition, when analysing 
the quadrant of each QRS axis, we discovered that 26% (46/176) of the QRS axes as 
calculated from the CE configuration lay within a different quadrant when compared to the 
corresponding QRS axes derived from the ML approach. As shown in Table 1, when using 
the CE configuration there is an 18% chance that the calculated QRS axis will misleadingly 
lie within the inferior right quadrant when the QRS axis should be ‘normal’. Thus, we found a 
weak correlation (r=0.26) between the QRS axes calculated from the ML and CE 
configurations. These results strongly indicate that the CE configuration does not facilitate 
reliable measurement of the QRS axis.  
 
Table 1. Shows the chance of changing quadrant of the QRS axis if the ECG is recorded 
using the CE configuration.  
Quadrant Chance  
Inferior right  18% 
Superior left  4% 
Superior right  2% 
Inferior left (Normal) 2% accounts for slightly abnormal axis that has become 
normal due to the CE configuration. 
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Figure 5. Box-plot of the absolute differences in QRS axis between the two 
configurations. (# of upper outliers = 18) 
 
Preliminary clinical observations 
Appendix 1 indicates the cases associated with the greatest composite scores. These 10 cases 
have been made available online [28]. The table indicates whether the clinician identified the 
ECGs in each case as having clinically relevant differences. The table also indicates the 
similarity rating given for each case (1 = very different, 10= very similar). With the mean 
similarity rating being 4.6 (SD=2.50) and the majority of ratings being between 1 and 4, this 
indicates that the CE configuration does affect the ECG signals from a clinical perspective. In 
addition, the clinician identified 6 out of 10 cases where the CE based ECG yielded different 
features that had clinical significance when compared to the usual ML configuration. There is 
a moderate correlation between the composite score and the similarity rating (r=-0.46) which 
validates the composite score. The table also showcases the detailed observations that were 
made during serial comparison. Recurring features involved more equiphasic leads  in the CE 
based ECG (R and S wave being the same length). The CE based ECG often amplified the 
signal (which was also verified in the quantitative analysis). As described in the table, the CE 
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approach can yield larger ST amplitudes. Perhaps this is due to the CE configuration 
accentuating early repolarisation.  
 
Discussion 
Figure 6 is an example case that shows the six limb leads recorded using the ML 
configuration alongside the corresponding leads recorded from the CE configuration. The 
figure shows a slight rightward change in the QRS axis when using the CE configuration. 
Although the difference is subtle in this case, right axis deviation (RAD) can allude to left 
posterior fascicular block or right ventricular hypertrophy [8]. Arguably, these pathologies are 
not generally monitored using telehealth devices and the shift in QRS axis may become well 
accepted. However, clinicians have considered the QRS axis in monitoring situations [24, 25].   
 
Figure 6 demonstrates that leads aVL, III and aVF are the most contrasting leads when 
comparing the configurations. Lead aVL is largely affected when using the CE configuration. 
As shown in Einthoven’s triangle (Figure 2a), the positive pole in this lead is derived from the 
LA electrode. And given the majority of the heart lies on the left side of the chest, the 
potentials recorded using the LA electrode are significantly different when it is moved from 
the left infraclavicular fossa to the left side of the chest. Even a small positional change in an 
electrode that is close to the heart can significantly alter the signal. Conversely, a small 
positional change on an electrode that is not close to the heart may only result in a small 
change to the signal [29, 30]. This rationale may help explain why lead aVR is less affected 
by the CE configuration when compared to lead aVL.  
 
The next most affected signal by the CE configuration is lead III. Using the same rationale, 
this could be due to the fact that lead III is derived using the LA and LL electrodes. These 
electrodes are in closer proximity to the heart when compared to the RA electrode. And when 
these electrodes are repositioned closer to the heart, lead III is significantly affected, 
especially regarding its amplitude. There may also be a similar explanation as to why lead 
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aVF is considerably different when using the CE configuration. The positive pole in lead aVF 
is provided by the LL electrode and when this electrode is positioned significantly closer to 
the heart, thus the amplitude of lead aVF is significantly enhanced.   
 
Although the aforementioned leads exhibit substantial morphological differences in the two 
configurations, lead II is almost identical. This can be seen in the example provided in Figure 
6 and in the metrics provided in Figure 4. Although the QRS amplitude in lead II is slightly 
increased in the CE configuration, the morphology of this lead is only mildly affected 
(r=0.91, SD=0.12). Given lead II is traditionally used for detecting rhythm disorders [8], this 
study indicates that a CE based lead II is reliable for arrhythmia detection.  
 
Figure 6 (A) Typical ECG recorded using the ML configuration and (B) the corresponding 
ECG recorded using the CE configuration (both recorded form the same patient at the same 
time). This case demonstrates the typical increase in amplitudes in leads III and aVF 
associated with the CE configuration. A substantial difference in lead aVL is also depicted. 
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Limitations 
There are a number of limitations to this study. To control this experiment we compared the 
ML configuration as per guidelines with one variant of the CE configuration whereas in the 
real world there would be some variability in electrode placement when using either the ML 
or the CE configuration. Another limitation is that the 10 cases that were visually inspected 
by a clinician are not representative since these 10 cases represent cases where the CE 
configuration has the most effect on a normal ECG. Therefore a future study will involve 
recruiting multiple clinicians (to consider inter-rater reliability) to interpret all cases in this 
study. An additional limitation is that whilst the clinician was blinded as to which ECG was 
derived from the CE or ML configuration, they could have had a systematic bias given the 
changes in the cardiac axis in the CE configuration being more rightward. 
 
Conclusions 
Leads aVL, III and aVF are the most contrasting leads when comparing the ML and CE 
configurations. We confirmed that the CE configuration simulates a slight rightward QRS 
axis, which can emulate pathologies such as right ventricular hypertrophy and right bundle 
branch block. However, lead II is reliable when using the CE configuration. Thus the CE 
approach is suitable for faithfully monitoring the heart’s rhythm. Given leads aVL, III and 
aVF are not reliable, the CE approach cannot be used for diagnosing pathologies that rely on 
specific amplitude criteria, that is unless new criteria are designed for the CE configuration. 
However, the development of new criteria is unrealistic, costly and time-consuming given the 
current criteria used in today’s practice was developed over the last 100 years through a 
significant amount of trials and data collection. In conclusion, such ECG electrode 
configurations for the context of CH [31-33] need to be enhanced to reliably detect CHD. 
And if these devices include computerized analysis then the results and limitations presented 
here need to be considered.  Future work may include conducting the same study using a 
larger database of BSPMs (this is possible given there are a large number of heterogeneous 
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BSPM databases at different research centers around the world [34] – however to date no 
work has been done to aggregate these datasets). 
 
 
 
References 
 
1. Lutz W, Sanderson W, Scherbov S. The coming acceleration of global population ageing. 
Nature. 2008;451:716-719. 
 
2. Reynolds L. The future of the NHS--irreversible privatisation? interview by jill mountford. 
BMJ. 2013;346:f1848. 
 
3. Caulfield BM, Donnelly SC. What is connected health and why will it change your 
practice? QJM. 2013;106:703-707. 
 
4. De San Miguel K, Smith J, Lewin G. Telehealth remote monitoring for community-
dwelling older adults with chronic obstructive pulmonary disease. Telemedicine and e-Health. 
2013;19:652-657. 
 
5. Woods LW, Snow SW. The impact of telehealth monitoring on acute care hospitalization 
rates and emergency department visit rates for patients using home health skilled nursing 
care. Home Healthc Nurse. 2013;31:39-45.  
 
 
6. Piotrowicz E, Jasionowska A, Banaszak-Bednarczyk M, Gwilkowska J, Piotrowicz R. 
ECG telemonitoring during home-based cardiac rehabilitation in heart failure patients. J 
Telemed Telecare. 2012;18:193-197. 
 
Page	  21	   	   	  
Page 21	   	  
7. Kligfield P, Gettes LS, Bailey JJ, et al. Recommendations for the standardization and 
interpretation of the electrocardiogram:: Part I: The electrocardiogram and its technology: A 
scientific statement from the American heart association electrocardiography and arrhythmias 
committee, council on clinical cardiology; the american college of cardiology foundation; and 
the heart rhythm society. endorsed by the international society for computerized 
electrocardiology. Heart Rhythm. 2007;4:394-412. 
 
8. Wagner GS, Marriott HJL. Marriott's Practical Electrocardiography. 11th ed. 
Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2008. 
9. Barold SS. Norman J.“Jeff” Holter–“Father” of ambulatory ECG monitoring. Journal of 
Interventional Cardiac Electrophysiology. 2005;14:117-118. 
 
10. Drew BJ, Califf RM, Funk M, et al. Practice standards for electrocardiographic 
monitoring in hospital settings an american heart association scientific statement from the 
councils on cardiovascular nursing, clinical cardiology, and cardiovascular disease in the 
young: Endorsed by the international society of computerized electrocardiology and the 
american association of critical-care nurses. Circulation. 2004;110:2721-2746. 
 
11. Donnelly N, Harper R, McCAnderson J, et al. Development of a ubiquitous clinical 
monitoring solution to improve patient safety and outcomes. IEEE; 2012:6068-6073. 
 
12. Jang Y, Noh HW, Lee I, Song Y, Shin S, Lee S. A basic study for patch type ambulatory 
3-electrode ECG monitoring system for the analysis of acceleration signal and the limb leads 
and augmented unipolar limb leads signal. IEEE; 2010:3864-3867. 
 
13. RealTime Technologies. Wearable Wireless Sensor Platform. Available at: 
http://www.shimmer-research.com. 
 
Page	  22	   	   	  
Page 22	   	  
14. Mason RE, Likar I. A new system of multiple-lead exercise electrocardiography. Am 
Heart J. 1966;71:196-205. 
 
15. Bond RR, Finlay DD, Nugent CD, Moore G. A web-based tool for processing and 
visualizing body surface potential maps. J Electrocardiol. 2010;43:560-565. 
 
16. Lux RL, Smith CR, Wyatt RF, Abildskov JA. Limited lead selection for estimation of 
body surface potential maps in electrocardiography. IEEE Transactions on Biomedical 
Engineering. 1978;25:270-276. 
 
17. Bond RR, Finlay DD, Nugent CD, Moore G, Guldenring D. A simulation tool for 
visualizing and studying the effects of electrode misplacement on the 12-lead 
electrocardiogram. J Electrocardiol. 2011;44:439-444. 
 
18. Kania M, Rix H, Fereniec M, et al. The effect of precordial lead displacement on ECG 
morphology. Med Biol Eng Comput. 2014;52:109-119. 
 
19. Finlay DD, Nugent CD, Nelwan SP, Bond RR, Donnelly MP, Guldenring D. Effects of 
electrode placement errors in the EASI-derived 12-lead electrocardiogram. J Electrocardiol. 
2010;43:606-611.  
 
20. Schijvenaars BJ, Kors JA, van Herpen G, Kornreich F, Van Bemmel J. Interpolation of 
body surface potential maps. J Electrocardiol. 1995;28:104-109. 
21. Bond RR, Finlay D, Nugent C, Breen C, Guldenring D, Daly M. The effects of electrode 
misplacement on clinicians’ interpretation of the standard 12-lead electrocardiogram. Eur J 
Intern Med. 2012;23:610-615. 
 
Page	  23	   	   	  
Page 23	   	  
22. Bond RR, Finlay DD, Nugent CD, Moore G, Guldenring D. A usability evaluation of 
medical software at an expert conference setting. Comput Methods Programs Biomed. 
2014;113:383-395. 
 
23. Bond RR. Electrode Misplacement Simulator. Available at: 
http://scm.ulster.ac.uk/~scmresearch/bond/ems/. 
 
24. Drew B. Standardization of electrode placement for continuous patient monitoring: 
Introduction of an assessment tool to compare proposed electrocardiogram lead 
configurations. J Electrocardiol. 2011;44:115-118. 
 
25. Wagner GS, Marriott HJL. Marriott's Practical Electrocardiography. 11th ed. 
Philadelphia: Wolters Kluwer Lippincott Williams & Wilkins; 2008. 
 
26. Hoseini S, Moeeny A, Shoar S, et al. Designing nomogram for determining the hearts 
QRS axis. Journal of Clinical and Basic Cardiology. 2012;14:12-15. 
 
27. Gari. Clifford G.D., Azuaje, F., McSharry P.E. (Eds): Advanced Methods and Tools for 
ECG Analysis. Artech House Publishing, October 2006. 
 
28. Bond RR. ECGs selected for serial comparison. Available at: 
http://scm.ulster.ac.uk/~scmresearch/bond/clincal_analysis_final.pdf 
 
29. Goldberger AL. Clinical Electrocardiography:A Simplified Approach. 5th ed. London: 
Mosby; 1994. 
 
30. Hampton JR. The ECG made Easy. 6th ed. Edinburgh ; New York: Churchill Livingstone; 
2003. 
Page	  24	   	   	  
Page 24	   	  
31. Angius G, Pani D, Raffo L, Randaccio P, Seruis S. A tele-home care system exploiting 
the DVB-T technology and MHP. Methods Inf Med. 2008;47:223-228.  
 
32. Bidargaddi N, Sarela A. Activity and heart rate-based measures for outpatient cardiac 
rehabilitation. Methods Inf Med. 2008;47:208-216.  
 
33. Spyropoulos B, Tzavaras A, Botsivaly M, Koutsourakis K. Ensuring the continuity of care 
of cardiorespiratory diseases at home. Methods Inf Med. 2010;49:156-160.  
 
34. Hoekema R, Uijen GJH, Van Oosterom A, "On selecting a body surface mapping 
procedure," J Electrocardiol., vol. 32, pp. 93-101, April, 1999. 
 
Page	  25	   	   	  
Page 25	   	  
Page	  26	   	   	  
Page 26	   	  
 
 
